Try a new search

Format these results:

Searched for:

person:rubena02

in-biosketch:yes

Total Results:

100


NEUROFIBROMATOSIS AND CHIASMAL GLIOMA - REAPPRAISAL FOR FUTURE MANAGEMENT [Meeting Abstract]

ARON, AM; TAFF, I; WALLACE, SA; RUBENSTEIN, A
ISI:A1986D933100066
ISSN: 0364-5134
CID: 102355

Neurofibromatosis

Rubenstein, Allan E; Bunge, Richard P; Housman, David E
New York NY : New York Academy of Sciences, 1986
Extent: 414 p. ; 24cm
ISBN: 0897663675
CID: 1901

Madelung's Deformity Associated with Von Recklinghausen Neurofibromatosis (VRNF); "Extension of the spectrum of Dysplastic Phenomena Associated with VRNF" [Meeting Abstract]

Taff IP; Handelsman J; Rubenstein AE; Aron A; Wallace S
ORIGINAL:0006650
ISSN: 0028-3878
CID: 102419

Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency [Case Report]

Goldberg, I J; Mazlen, R G; Rubenstein, A; Gibson, J C; Paterniti, J R Jr; Lindgren, F T; Brown, W V
Two enzymes, lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL), are released into human plasma after intravenous injection of heparin. LPL is the major enzyme responsible for initiating catabolism of chylomicrons and very-low-density lipoproteins (VLDL). The physiological role of HTGL is less certain. HTGL has been postulated to be an alternate enzyme to LPL in hydrolysis of triglyceride in VLDL and to be an important enzyme for removal of phospholipid from both low-density lipoproteins (LDL) and high-density lipoproteins (HDL). In this latter role, this enzyme would convert larger, lighter lipoprotein particles to smaller denser particles. HTGL deficiency has been found in severe liver disease and with a genetic deficiency of this enzyme. A unique patient is described with acquired hepatic triglyceride lipase deficiency and vitamin A intoxication. This patient developed hypercholesterolemia with an increase in both LDL and HDL. An increased proportion of lighter LDL (LDL1) and HDL (HDL2) was noted. In addition, after administration of heparin there was no shift in the distribution of apoE in plasma fractionated using a column containing 4% agarose. These findings are consistent with a postulated role of HTGL in metabolism of light LDL and HDL particles and some classes of apoE containing lipoproteins.
PMID: 4033424
ISSN: 0026-0495
CID: 952542

Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells

Sobue, G; Sonnenfeld, K; Rubenstein, A E; Pleasure, D
Six dermal neurofibromas obtained from 5 patients with neurofibromatosis were dissociated and the cells were plated on polylysine-coated glass. Two principal cell types were observed in the cultures: elongated and bipolar Schwann-like cells (SLCs), and polymorphic flattened fibroblast-like cells (FLCs). Indirect immunofluorescence demonstrated that SLCs expressed surface laminin but not surface fibronectin; FLCs expressed surface fibronectin but were only weakly positive for surface laminin. Tritiated thymidine autoradiography demonstrated that cultured SLCs proliferated slowly (labeling index, 0.7 to 4.0%), whereas FLCs divided more rapidly (labeling index, 7.5 to 26.4%). Axolemmal fragments prepared from human or rat central nervous system specimens adhered to SLCs derived from each of the 6 neurofibromas, but not to FLCs. Axolemmal fragments induced a marked proliferative response of SLCs from 2 of the 6 neurofibromas but had no effect on proliferation of SLCs from the other 4 neurofibromas or FLCs from any of the 6 neurofibromas. In one patient from whom 2 neurofibromas were obtained, SLCs from one neurofibroma responded to axolemmal fragments, while SLCs from the other did not. Treatment of the cultures with 0.1 mM cyclic adenosine 3'5'-monophosphate (cAMP) analogue, 8-bromo cAMP, caused marked inhibition of proliferation of both SLCs and FLCs derived from all 6 neurofibromas. The same concentration of another cAMP analogue, dibutyryl cAMP, inhibited proliferation of SLCs but not of FLCs
PMID: 2994552
ISSN: 0364-5134
CID: 90850

Autonomic neuropathy associated with autoimmune disease [Case Report]

Gudesblatt, M; Goodman, A D; Rubenstein, A E; Bender, A N; Choi, H S
Mononeuropathy multiplex and mixed sensorimotor neuropathy are known complications of systemic vasculitis and related autoimmune disorders. Autonomic dysfunction is not generally considered a neurologic complication of these diseases. We report two patients who came to neurologic attention because of autonomic dysfunction and were then discovered to have autoimmune disease. Autonomic dysfunction may be the presenting sign of autoimmune disorders, which should be considered in the differential diagnosis of acquired autonomic disturbances
PMID: 3969218
ISSN: 0028-3878
CID: 90858

LACK OF CORRELATION OF MEGALENCEPHALY WITH LEARNING DISABILITY IN DISSEMINATED NEUROFIBROMATOSIS [Meeting Abstract]

RUBENSTEIN A; WALLERSTEIN R; ARON A; WALLACE S
BIOSIS:PREV198630019730
ISSN: 0002-9297
CID: 102358

INCREASED RISK OF CONGENITAL PREMALIGNANT MELANOCYTIC NEVI IN NEUROFIBROMATOSIS [Meeting Abstract]

RUBENSTEIN A E; SEITZ S C; WALLACE S; ARON A M; LEBWOHL M
BIOSIS:PREV198529045042
ISSN: 0028-3878
CID: 102357

Patterns of daytime sleepiness in narcoleptics and normals: a pupillometric study

Pressman, M R; Spielman, A J; Korczyn, A D; Rubenstein, A E; Pollak, C P; Weitzman, E D
Pupil diameter was measured in light and dark conditions every half hour for 6.5-10 h in 3 normal controls and 3 narcoleptics. Mean pupillary diameter was significantly smaller in the narcoleptic group than in the normal group. Pupil activity was correlated with pupil diameter only in the dark condition in narcoleptics. Pupil diameter varied with a circa 90 min periodicity in the narcoleptics but not in the normal controls. These results indicate firstly, that one-time assessment of pupil size is insufficient; and secondly, that the appearance of these rhythms may be the result of a defect in arousal mechanisms of narcoleptics which usually play an inhibitory role
PMID: 6198153
ISSN: 0013-4694
CID: 90862

NEUROLOGICAL COMPLICATIONS IN 250 CASES OF NEUROFIBROMATOSIS [Meeting Abstract]

RUBENSTEIN, AE; WALLACE, S; ARON, AM; PENCHAZADEH, G
ISI:A1984TA19100117
ISSN: 0364-5134
CID: 102359